Global human microbiome market projected to reach $4.85 billion by 2031, showing significant growth
From GlobeNewswire: 2025-02-06 07:23:00
A comprehensive report from The Insight Partners reveals significant growth in the global human microbiome market, with projections to reach US$4.85 billion by 2031. Key players are heavily investing in research and development, with Kanvas Biosciences receiving US$12 million in funding and Nestle collaborating with APC Microbiome Ireland. Government initiatives and geographic insights are also driving market growth.
The report highlights the impact of government initiatives on the human microbiome market, with the NIH providing significant funding for research. Regulatory frameworks are improving, with the FDA approving Seres’ VOWST as the first oral microbiome therapy. Geographic insights show North America leading the market in 2023, with Asia Pacific expected to record the highest CAGR.
Major companies in the human microbiome market include MaaT Pharma, Ferring Holdings SA, and Seres Therapeutics Inc. Trending topics include probiotics, prebiotics, and live biotherapeutics. Recent developments include MaaT Pharma’s positive DSMB review and Seres Therapeutics’ FDA clearance for an investigational microbiome therapeutic.
Market segmentation reveals product and software and services as key segments, with a focus on therapeutics, diagnostics, and research applications. The market is further segmented by disease type, with the GIT segment dominating in 2023. Regional segmentation includes North America, Europe, APAC, the Middle East & Africa, and South & Central America.
The human microbiome market is driven by increasing research, diagnostics, and demand for personalized medicine. Stakeholders are investing in microbiome research for early-stage disease detection, with regulatory institutions offering supportive policies. Collaboration between major players and research institutions is driving innovation and growth in the market.
The Insight Partners report provides valuable insights for manufacturers, physicians, patients, and end users navigating the evolving human microbiome market. With continuous research and technological advancements, the market is expected to grow robustly, applying microbiome science to improve human health.
Read more at GlobeNewswire: Human Microbiome Market Size to Surge to $4.85 Billion by